Delving into the Latest Updates on Cristal Delivery BV with Synapse

The purpose of this study is to determine whether CPC634 (CriPec® docetaxel) is effective in the treatment of patients with advanced epithelial ovarian cancer who are resistant to prior platinum-based chemotherapy
.

开始日期2018-10-01

申办/合作机构

Cristal Delivery BV

NCT03712423

/ Completed临床1期IIT

A Clinical Phase I, Open-label, PET Study With [89Zr]-Df-CriPec® Docetaxel in Patients With Solid Tumours to Assess Biodistribution and Tumour Accumulation of [89Zr]-Df-CriPec® Docetaxel

A clinical phase I, open-label PET study with [89Zr]-Df-CriPec® docetaxel in patients with solid tumours to assess biodistribution and tumour accumulation of [89Zr]-Df-CriPec® docetaxel.

开始日期2018-04-01

申办/合作机构

Stichting Onderzoek Cancer Center Amsterdam

[+1]

NCT02442531

/ Completed临床1期

A Phase I Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of CriPec® Docetaxel in Patients With Solid Tumours

The goal of this Phase1 clinical research study is to find the highest safe dose of CriPec® docetaxel that can be given in the treatment of patients with solid tumours.

开始日期2015-08-01

申办/合作机构

Cristal Delivery BV

100 项与 Cristal Delivery BV 相关的临床结果

登录后查看更多信息

0 项与 Cristal Delivery BV 相关的专利（医药）

登录后查看更多信息

100 项与 Cristal Delivery BV 相关的药物交易

登录后查看更多信息

100 项与 Cristal Delivery BV 相关的转化医学

登录后查看更多信息